Sponsored by Intact Vascular
Toba II portal banner

Tack Endovascular System (6F) is FDA approved for SFA and proximal popliteal (3.5-6.0mm RVD) treatment of post-PTA dissections.

Download PDF


Your 25-second video preview has ended.

to continue watching, please Log In or Register:

Log in / Register

Angioplasty commonly results in dissections and current options (primarily stents) may limit future treatment. Dr. William A. Gray (TOBA II National Principal Investigator, System Chief of Cardiovascular Services at Main Line Health and President of Lankenau Heart Institute) presents his thoughts on the Tack Endovascular System®. He describes a unique and novel approach with minimal metal implant, low continual outward force, a single SKU and potentially low inflammation rates. Dr. Gray shares data from multiple clinical trials both Above the Knee (ATK) and Below the Knee (BTK).

TOBA Clinical Studies Program

Download PDF

Follow @intactvascular


Learn More at intactvascular.com